Cor Vasa 2017, 59(5):e424-e429
Obstructive hypertrophic cardiomyopathy and aortic valve disease in elderly woman - a case for Cath lab or surgery?
- a I. interní kardioangiologická klinika, Fakultní nemocnice u sv. Anny v Brně, Brno, Česká republika
- b Centrum kardiovaskulární a transplantační chirurgie, Brno, Česká republika
- c Lékařská fakulta Masarykovy univerzity, Brno, Česká republika
Aim: Hypertrophic cardiomyopathy (HCM) is a relatively common genetic cardiac disease (1 : 500) that is largely heterogeneous in its presentation, prognosis and treatment strategies. As such it often represents a dilemma to primary care clinicians as well as cardiovascular specialists. With widening possibilities of the management of the disease it is important to bring relevant clinical cases, which can help to clarify often difficult questions, which may arise.
Methods/case presentation: We are reporting a case of 74-year-old woman with highly symptomatic obstructive hypertrophic cardiomyopathy (HOCM) in concomitance with mild and hemodynamically insignificant aortic valve steno-insufficiency with limiting symptoms refractory to maximal medical management, who was referred to our medical center for consideration of the optimal interventional treatment strategy.
Results: The patient underwent alcohol septal ablation with good immediate, but suboptimal long-term clinical effect. Within 1 year, the initially insignificant aortic stenosis progressed together with regeneration of the septal hypertrophy, thus the treatment strategy followed by combined surgical septal myectomy and aortic valve replacement and eventually even mitral valve replacement due to intraoperative complication. The 1-year follow-up showed optimal therapeutic effect. In Europe, alcohol septal ablation became a preferred initial interventional method for symptomatic patients with HOCM, especially for elderly patients with comorbidities. This case illustrates the fact that surgical septal myectomy complemented by the repair or replacement of valves, may be, for selected patients, method of choice even in our country.
Conclusion: We would like to emphasize the importance of the appropriate selection of patients for the intervention within this heterogeneous disease spectrum, especially patients with combined HOCM and valvular disease and underline the necessity of proper evaluation of the treatment strategy for each individual patient.
Keywords: Alcohol septal ablation; Aortic valve disease; Hypertrophic cardiomyopathy; Surgical septal myectomy
Received: June 16, 2016; Accepted: August 17, 2016; Published: October 1, 2017 Show citation
References
- P.M. Elliott, A. Anastasakis, M.A. Borger, et al., 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), European Heart Journal 35 (2014) 2733-2779.
Go to original source...
- B.J. Gersh, B.J. Maron, R.O. Bonow, et al., 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Journal of the American College of Cardiology 58 (2011) e212-e260.
Go to original source...
Go to PubMed...
- M. Alam, H. Dokainish, N.M. Lakkis, Hypertrophic obstructive cardiomyopathy - alcohol septal ablation vs. myectomy: a meta-analysis, European Heart Journal 30 (2009) 1080-1087.
Go to original source...
Go to PubMed...
- P. Sorajja, S.R. Ommen, D.R. Holmes, et al., Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation 126 (2012) 2374-2380.
Go to original source...
Go to PubMed...
- J. Veselka, J. Krejčí, P. Tomašov, D. Zemánek, Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population, European Heart Journal 35 (2014) 2040-2045.
Go to original source...
Go to PubMed...
- J. Veselka, D. Zemánek, D. Jahnlová, et al., Risk and causes of death in patients after alcohol septal ablation for hypertrophic obstructive cardiomyopathy, Canadian Journal of Cardiology 31 (2015) 1245-1251.
Go to original source...
Go to PubMed...
- B.J. Maron, J.A. Dearani, S.R. Ommen, et al., The case for surgery in obstructive hypertrophic cardiomyopathy, Journal of the American College of Cardiology 44 (2004) 2044-2053.
Go to original source...
Go to PubMed...
- S.S. Panaich, A.O. Badheka, A. Chothani, et al., Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010]), American Journal of Cardiology 114 (2014) 1390-1395.
Go to original source...
Go to PubMed...
- A. Iacovoni, P. Spirito, C. Simon, et al., A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy, European Heart Journal 33 (2012) 2080-2087.
Go to original source...
Go to PubMed...